Flamingo Therapeutics
Leuven
About Flamingo Therapeutics
Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.9M
- Last round: Grant (Jun 2023)
- Website: flamingotx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Oncology
Social Profiles
Canonical: https://fsome.com/organization/flamingo-therapeutics-90602 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.